Evidence map›Paper›PMID 21049985›Full record

ArticleJournal of proteome research2011

Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain.

Wei-Li Liao, Gun-Young Heo, Nathan G Dodder, Rachel E Reem, Natalia Mast, Suber Huang, Pier Luigi Dipatre, Illarion V Turko, Irina A Pikuleva

Abstract read
In one paragraph

Article in Journal of proteome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Oxysterols as Biomarkers of Aging and Disease.Advances in experimental medicine and biology · 2024
    Article
  7. Challenges and Opportunities in P450 Research on the Eye.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Wei-Li LiaoInstitute for Bioscience and Biotechnology Research, Rockville, Maryland 20850, USA.
Gun-Young Heo
Nathan G Dodder
Rachel E Reem
Natalia Mast
Suber Huang
Pier Luigi Dipatre
Illarion V Turko
Irina A Pikuleva
Case Western Reserve University · USNational Institute of Standards and Technology · USInstitute for Bioscience and Biotechnology ResearchThe University of Texas Medical Branch at Galveston · US

Funding

Significance of CYP46A1 and other P450s in retinal functionR01EY018383 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PIKULEVA, IRINA A · 2007 to 2024
$6.8M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Cholesterol-metabolizing P450s and Alzheimer's diseaseK02AG024336 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI PIKULEVA, IRINA A · 2005 to 2009
$515k
NEI NIH HHS EY018383NEI NIH HHS R01 EY018383NEI NIH HHS T32 EY007157NEI NIH HHS T32 EY07157NIA NIH HHS AG024336NIA NIH HHS K02 AG024336
6 · The paper itself

Abstract

Cytochrome P450 enzymes (CYP or P450) 46A1 and 27A1 play important roles in cholesterol elimination from the brain and retina, respectively, yet they have not been quantified in human organs because of their low abundance and association with membrane. On the basis of our previous development of a multiple reaction monitoring (MRM) workflow for measurements of low-abundance membrane proteins, we quantified CYP46A1 and CYP27A1 in human brain and retina samples from four donors. These enzymes were quantified in the total membrane pellet, a fraction of the whole tissue homogenate, using ¹⁵N-labled recombinant P450s as internal standards. The average P450 concentrations/mg of total tissue protein were 345 fmol of CYP46A1 and 110 fmol of CYP27A1 in the temporal lobe, and 60 fmol of CYP46A1 and 490 fmol of CYP27A1 in the retina. The corresponding P450 metabolites were then measured in the same tissue samples and compared to the P450 enzyme concentrations. Investigation of the enzyme-product relationships and analysis of the P450 measurements based on different signature peptides revealed a possibility of retina-specific post-translational modification of CYP27A1. The data obtained provide important insights into the mechanisms of cholesterol elimination from different neural tissues.

Indexed as

Cell MembraneCholestanetriol 26-MonooxygenaseCholestenesCholesterolCholesterol 24-HydroxylaseHumansHydroxycholesterolsIsotope LabelingMass SpectrometryNitrogen IsotopesReproducibility of ResultsRetinaSteroid HydroxylasesTemporal Lobe24-hydroxycholesterol27-hydroxycholesterolCholestanetriol 26-MonooxygenaseCholestenescholestenoic acidCholesterolCholesterol 24-HydroxylaseCYP27A1 protein, humanHydroxycholesterolsNitrogen IsotopesSteroid Hydroxylases

Identifiers

PMID21049985
PMCPMC3064498
OpenAlexW2115237409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.